ABT-510 in Treating Patients With Metastatic Melanoma

NCT00602199 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

DRUG: ABT-510
OTHER: immunoenzyme technique
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis
OTHER: pharmacological study
PROCEDURE: biopsy

Sponsor

Mayo Clinic

Collaborators

[object Object]